The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carey, G. B.
Right arrow Articles by Scott, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carey, G. B.
Right arrow Articles by Scott, D. W.
The Journal of Immunology, 2001, 166: 1618-1626.
Copyright © 2001 by The American Association of Immunologists

Role of Phosphatidylinositol 3-Kinase in Anti-IgM- and Anti-IgD-Induced Apoptosis in B Cell Lymphomas1 ,2

Gregory B. Carey and David W. Scott3

Department of Immunology, Holland Laboratory of the American Red Cross, Rockville, MD 20855

Cross-linking of surface Ig receptors with anti IgM (anti-µ heavy chain, anti-µ), but not anti-IgD (anti-{delta} heavy chain, anti-{delta}), Abs leads to growth arrest and apoptosis in several extensively characterized B cell lymphomas. By poorly understood mechanisms, both Igs transiently stimulate c-Myc protein expression. However, ultimately, only anti-µ causes a severe loss in c-Myc and a large induction of p27Kip1 protein expression. Because phosphatidylinositol 3-kinase (PI3K) has been established as a major modulator of cellular growth and survival, we investigated its role in mediating anti-Ig-stimulated outcomes. Herein, we show that PI3K pathways regulate cell cycle progression and apoptosis in the ECH408 B cell lymphoma. Anti-µ and anti-{delta} driven c-Myc protein changes precisely follow their effects on the PI3K effector, p70S6K. Upstream of p70S6K, signaling through both Ig receptors depresses PI3K pathway phospholipids below control with time, which is followed by p27Kip1 induction. Conversely, anti-{delta}, but not anti-µ stimulated PI3K-dependent phospholipid return to control levels by 4–8 h. Abrogation of the PI3K pathway with specific inhibitors mimics anti-µ action, potentiates anti-µ-induced cell death and, importantly, converts anti-{delta} to a death signal. Transfection with active PI3K kinase construct induces anti-µ resistance, whereas transfection with dominant negative PI3K augments anti-µ sensitivity. Our results show that prolonged disengagement of PI3K or down-regulation of its products by anti-µ (and not anti-{delta}) determines B cell fate.




This article has been cited by other articles:


Home page
BloodHome page
A. Hachem and R. B. Gartenhaus
Oncogenes as molecular targets in lymphoma
Blood, September 15, 2005; 106(6): 1911 - 1923.
[Full Text] [PDF]


Home page
J. Immunol.Home page
V. Chandramohan, S. Jeay, S. Pianetti, and G. E. Sonenshein
Reciprocal Control of Forkhead box O 3a and c-Myc via the Phosphatidylinositol 3-Kinase Pathway Coordinately Regulates p27Kip1 Levels
J. Immunol., May 1, 2004; 172(9): 5522 - 5527.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Muscarella and S. E. Bloom
Cross-linking of Surface IgM in the Burkitt's Lymphoma Cell Line ST486 Provides Protection against Arsenite- and Stress-induced Apoptosis That Is Mediated by ERK and Phosphoinositide 3-Kinase Signaling Pathways
J. Biol. Chem., January 31, 2003; 278(6): 4358 - 4367.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-F. Qi, A. Martensson, M. Mattioli, R. Dalla-Favera, V. V. Lobanenkov, and H. C. Morse III
CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells
PNAS, January 21, 2003; 100(2): 633 - 638.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.